View in EDS

119O Event-free survival (EFS), overall survival (OS), and safety of adding veliparib (V) plus carboplatin (Cb) or carboplatin alone to neoadjuvant chemotherapy in triple-negative breast cancer (TNBC) after ≥4 years of follow-up: BrighTNess, a randomized phase III trial

Saved in:
Bibliographic Details
Title: 119O Event-free survival (EFS), overall survival (OS), and safety of adding veliparib (V) plus carboplatin (Cb) or carboplatin alone to neoadjuvant chemotherapy in triple-negative breast cancer (TNBC) after ≥4 years of follow-up: BrighTNess, a randomized phase III trial
Authors: Loibl, S.1 (AUTHOR), Sikov, W.2 (AUTHOR), Huober, J.3 (AUTHOR), Rugo, H.S.4 (AUTHOR), Wolmark, N.5 (AUTHOR), O'Shaughnessy, J.6 (AUTHOR), Maag, D.7 (AUTHOR), Untch, M.8 (AUTHOR), Golshan, M.9 (AUTHOR), Lorenzo, J. Ponce10 (AUTHOR), Metzger, O.11 (AUTHOR), Dunbar, M.12 (AUTHOR), Symmans, W.F.13 (AUTHOR), Geyer, C.14 (AUTHOR)
Source: Annals of Oncology. 2021 Supplement 5, Vol. 32, pS408-S408. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 152688748
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 119O Event-free survival (EFS), overall survival (OS), and safety of adding veliparib (V) plus carboplatin (Cb) or carboplatin alone to neoadjuvant chemotherapy in triple-negative breast cancer (TNBC) after ≥4 years of follow-up: BrighTNess, a randomized phase III trial
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Loibl%2C+S%2E%22">Loibl, S.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sikov%2C+W%2E%22">Sikov, W.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Huober%2C+J%2E%22">Huober, J.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rugo%2C+H%2ES%2E%22">Rugo, H.S.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wolmark%2C+N%2E%22">Wolmark, N.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22O'Shaughnessy%2C+J%2E%22">O'Shaughnessy, J.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Maag%2C+D%2E%22">Maag, D.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Untch%2C+M%2E%22">Untch, M.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Golshan%2C+M%2E%22">Golshan, M.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lorenzo%2C+J%2E+Ponce%22">Lorenzo, J. Ponce</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Metzger%2C+O%2E%22">Metzger, O.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dunbar%2C+M%2E%22">Dunbar, M.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Symmans%2C+W%2EF%2E%22">Symmans, W.F.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Geyer%2C+C%2E%22">Geyer, C.</searchLink><relatesTo>14</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2021 Supplement 5, Vol. 32, pS408-S408. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=152688748
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2021.08.400
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: S408
    Titles:
      – TitleFull: 119O Event-free survival (EFS), overall survival (OS), and safety of adding veliparib (V) plus carboplatin (Cb) or carboplatin alone to neoadjuvant chemotherapy in triple-negative breast cancer (TNBC) after ≥4 years of follow-up: BrighTNess, a randomized phase III trial
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Loibl, S.
      – PersonEntity:
          Name:
            NameFull: Sikov, W.
      – PersonEntity:
          Name:
            NameFull: Huober, J.
      – PersonEntity:
          Name:
            NameFull: Rugo, H.S.
      – PersonEntity:
          Name:
            NameFull: Wolmark, N.
      – PersonEntity:
          Name:
            NameFull: O'Shaughnessy, J.
      – PersonEntity:
          Name:
            NameFull: Maag, D.
      – PersonEntity:
          Name:
            NameFull: Untch, M.
      – PersonEntity:
          Name:
            NameFull: Golshan, M.
      – PersonEntity:
          Name:
            NameFull: Lorenzo, J. Ponce
      – PersonEntity:
          Name:
            NameFull: Metzger, O.
      – PersonEntity:
          Name:
            NameFull: Dunbar, M.
      – PersonEntity:
          Name:
            NameFull: Symmans, W.F.
      – PersonEntity:
          Name:
            NameFull: Geyer, C.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: 2021 Supplement 5
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 32
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1